Johnson & Johnson  

(Public, NYSE:JNJ)   Watch this stock  
Find more results for JNJ
127.26
+0.26 (0.20%)
Pre-market: 127.26 0.00 (0.00%)
May 23, 8:01AM EDT  
NYSE real-time data - Disclaimer
Currency in USD
Range 126.63 - 127.65
52 week 109.32 - 129.00
Open 126.63
Vol / Avg. 301.00/5.46M
Mkt cap 342.90B
P/E 21.39
Div/yield 0.84/2.64
EPS 5.95
Shares 2.69B
Beta 0.79
Inst. own 68%
Jul 18, 2017
Q2 2017 Johnson & Johnson Earnings Release - 9:30AM EDT - Add to calendar
Jun 8, 2017
Johnson & Johnson at Jefferies Healthcare Conference - 10:00AM EDT - Add to calendar
May 23, 2017
Johnson & Johnson at UBS Global Healthcare Conference - 10:00AM EDT - Add to calendar
May 17, 2017
Johnson & Johnson to Host Pharmaceutical Business Review - Webcast
Apr 27, 2017
Johnson & Johnson Annual Shareholders Meeting - Webcast
Apr 25, 2017
Johnson & Johnson Presents at MedTech Strategist Innovation Summit: Dublin 2017, Apr-25-2017 03:30 PM
Apr 18, 2017
Q1 2017 Johnson & Johnson Earnings Release
Apr 18, 2017
Q1 2017 Johnson & Johnson Earnings Call - Webcast
Mar 27, 2017
Johnson & Johnson at Sachs Associates Neuroscience BioPartnering & Investment Forum
Mar 14, 2017
Johnson & Johnson at Barclays Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q2 (Apr '17) 2017
Net profit margin 24.89% 23.01%
Operating margin 31.38% 27.55%
EBITD margin - 35.46%
Return on average assets 12.40% 12.05%
Return on average equity 25.20% 23.37%
Employees 126,400 -
CDP Score - A-

Address

1 Johnson And Johnson Plz
NEW BRUNSWICK, NJ 08933-0001
United States - Map
+1-732-5242455 (Phone)
+1-732-2140332 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Officers and directors

Alex Gorsky Chairman of the Board, Chief Executive Officer
Age: 56
Bio & Compensation  - Reuters
Dominic J. Caruso Chief Financial Officer, Executive Vice President
Age: 59
Bio & Compensation  - Reuters
Sandra E. Peterson Executive Vice President - Group Worldwide Chairman
Age: 58
Bio & Compensation  - Reuters
Peter M. Fasolo Ph.D. Chief Human Resource Officer, Executive Vice President
Age: 54
Bio & Compensation  - Reuters
Paulus A. Stoffels Executive Vice President, Chief Scientific Officer
Age: 55
Bio & Compensation  - Reuters
Michael H. Ullmann Executive Vice President, General Counsel
Age: 58
Bio & Compensation  - Reuters
Joaquin Duato Executive Vice President, Worldwide Chairman - Pharmaceuticals
Age: 54
Bio & Compensation  - Reuters
Jorge S. Mesquita Executive Vice President, Worldwide Chairman - Consumer
Age: 55
Bio & Compensation  - Reuters
Gary Pruden Executive Vice President - Worldwide Chairman, Medical Devices
Age: 55
Bio & Compensation  - Reuters
Joseph Wolk Vice President - Investor Relations
Bio & Compensation  - Reuters